These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 19783891)

  • 21. [Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma].
    Kim YI; Ki HS; Kim MH; Cho DK; Cho SB; Joo YE; Kim HS; Choi SK; Rew JS
    Korean J Hepatol; 2009 Jun; 15(2):148-58. PubMed ID: 19581767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidisciplinary management of nonresectable hepatocellular carcinoma.
    Park HC; Seong J; Tanaka M; Zeng ZC; Lim HY; Guan S; Bae SH; Tak WY
    Oncology; 2011; 81 Suppl 1():134-40. PubMed ID: 22212947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real practice of hepatocellular carcinoma in Japan: conclusions of the Japan Society of Hepatology 2009 Kobe Congress.
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():180-8. PubMed ID: 20616602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Practice guideline for diagnosis and treatment of hepatocellular carcinoma].
    Park JW;
    Korean J Hepatol; 2004 Jun; 10(2):88-98. PubMed ID: 15218342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early hepatocellular carcinoma: pathology, imaging, and therapy.
    Takayama T; Makuuchi M; Kojiro M; Lauwers GY; Adams RB; Wilson SR; Jang HJ; Charnsangavej C; Taouli B
    Ann Surg Oncol; 2008 Apr; 15(4):972-8. PubMed ID: 18236118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatocellular carcinoma. Pathogenesis and multicentricity].
    Blum HE; Hopt UT
    Chirurg; 2003 Aug; 74(8):709-16. PubMed ID: 12928791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of hepatocellular carcinoma in renal transplant recipients.
    Chok KS; Lam CM; Li FK; Ng KK; Poon RT; Lo CM; Fan ST
    J Surg Oncol; 2004 Sep; 87(3):139-42. PubMed ID: 15334642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for the management of hepatocellular carcinoma.
    Schwartz M; Roayaie S; Konstadoulakis M
    Nat Clin Pract Oncol; 2007 Jul; 4(7):424-32. PubMed ID: 17597707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
    Cunningham SC; Tsai S; Marques HP; Mira P; Cameron A; Barroso E; Philosophe B; Pawlik TM
    Ann Surg Oncol; 2009 Jul; 16(7):1820-31. PubMed ID: 19267161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
    J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma.
    Marrero JA; Pelletier S
    Clin Liver Dis; 2006 May; 10(2):339-51, ix. PubMed ID: 16971265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of hepatocellular carcinoma.
    El-Serag HB; Marrero JA; Rudolph L; Reddy KR
    Gastroenterology; 2008 May; 134(6):1752-63. PubMed ID: 18471552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic resection for hepatocellular carcinoma in elderly patients.
    Yeh CN; Lee WC; Jeng LB; Chen MF
    Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.